Clinical Trial Update: Effect of Simvastatin on CF Airway Inflammation [Phase 1]

View source ↗

Summary

Phase 1 trial evaluated whether simvastatin influences airway inflammation in cystic fibrosis patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Akron Children's Hospital | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED